Helen of Troy (NASDAQ:HELE) Stock Rating Lowered by Zacks Research

by · The Cerbat Gem

Helen of Troy (NASDAQ:HELE – Get Free Report) was downgraded by investment analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports.

HELE has been the topic of several other reports. Canaccord Genuity Group boosted their target price on Helen of Troy from $18.00 to $23.00 and gave the stock a “hold” rating in a research note on Friday, April 24th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Helen of Troy in a research note on Wednesday, June 24th. UBS Group raised their price target on Helen of Troy from $16.00 to $25.00 and gave the stock a “neutral” rating in a report on Friday, April 24th. Finally, Wall Street Zen lowered Helen of Troy from a “buy” rating to a “hold” rating in a research note on Saturday, May 23rd. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $24.00.

View Our Latest Analysis on HELE

Helen of Troy Trading Up 1.9%

NASDAQ:HELE opened at $28.04 on Monday. The stock has a market capitalization of $653.05 million, a price-to-earnings ratio of -0.72 and a beta of 1.31. Helen of Troy has a 52 week low of $13.85 and a 52 week high of $31.98. The company has a quick ratio of 0.81, a current ratio of 1.71 and a debt-to-equity ratio of 0.95. The firm has a 50 day moving average of $26.12 and a 200 day moving average of $20.82.

Helen of Troy (NASDAQ:HELE – Get Free Report) last released its quarterly earnings results on Thursday, April 23rd. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.09. The business had revenue of $470.03 million for the quarter, compared to analyst estimates of $450.38 million. Helen of Troy had a negative net margin of 50.33% and a positive return on equity of 7.00%. The business’s revenue for the quarter was down 3.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.33 earnings per share. Helen of Troy has set its FY 2027 guidance at 3.250-3.750 EPS. As a group, sell-side analysts anticipate that Helen of Troy will post 2.81 earnings per share for the current fiscal year.

Institutional Trading of Helen of Troy

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. RWWM Inc. grew its stake in Helen of Troy by 85.7% during the 1st quarter. RWWM Inc. now owns 1,173,829 shares of the company’s stock valued at $16,927,000 after purchasing an additional 541,689 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Helen of Troy by 164.9% during the fourth quarter. Millennium Management LLC now owns 1,049,381 shares of the company’s stock worth $22,299,000 after purchasing an additional 653,300 shares during the period. Paradigm Capital Management Inc. NY lifted its holdings in shares of Helen of Troy by 64.3% during the first quarter. Paradigm Capital Management Inc. NY now owns 927,100 shares of the company’s stock worth $13,369,000 after purchasing an additional 362,900 shares during the period. Charles Schwab Investment Management Inc. boosted its position in Helen of Troy by 24.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 881,344 shares of the company’s stock valued at $18,729,000 after buying an additional 175,696 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in Helen of Troy by 159.2% in the third quarter. Wellington Management Group LLP now owns 747,220 shares of the company’s stock valued at $18,830,000 after buying an additional 458,979 shares during the last quarter.

Key Helen of Troy News

Here are the key news stories impacting Helen of Troy this week:

  • Positive Sentiment: Canaccord Genuity kept a Hold rating on Helen of Troy and left its $23 price target unchanged, suggesting the analyst sees the current setup as mixed but not deteriorating further. Article Title
  • Positive Sentiment: Zacks highlighted Helen of Troy as a “Fast-Paced Momentum at a Bargain” stock, reinforcing the idea that recent trading strength may still have room to continue if investors focus on valuation and momentum. Article Title
  • Neutral Sentiment: Several entertainment articles about “Helen of Troy” and “The Odyssey” surfaced, but they are unrelated to Helen of Troy Limited’s business and are unlikely to affect HELE shares.
  • Negative Sentiment: Multiple law firms issued investor alerts about a class-action lawsuit against Helen of Troy Limited, with deadlines approaching for investors who may have suffered losses. That legal overhang can weigh on sentiment and raise uncertainty around the stock. Article Title

About Helen of Troy

(Get Free Report)

Helen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.

Further Reading